How should teams estimate 510(k) evidence gaps before submission?

Start with a section-level evidence inventory, score each section for completeness, and quantify the time and external testing effort needed to close gaps before eSTAR packaging.

Can missing test reports trigger delays even if the device is low risk?

Yes. Missing or inconsistent evidence can trigger Refuse to Accept (RTA) issues or additional information cycles, adding weeks or months depending on what evidence is missing and how quickly it can be generated.

Do these estimators replace regulatory judgment?

No. These are planning tools to organize work and prioritize remediation. Final submission strategy should be reviewed by qualified regulatory professionals.

How can teams prioritize which testing gaps to close first?

Prioritize evidence workstreams that both block other sections and carry high uncertainty, then compare baseline versus accelerated sequencing to reduce critical-path delay before filing.

FDA 510(k) Testing Evidence Gap Estimator

Use this utility page to quantify where your evidence package is weak, estimate closure effort, and decide whether to file now or remediate first. This page is built for 510(k) planning teams preparing eSTAR submissions.

Need End-to-End 510(k) Execution Support?

After you estimate gaps, move into a full filing workflow with classification, predicate work, section drafting, and packaging controls.

Go to 510(k) Submission Services

How to Use This Utility

Score current evidence readiness for each major testing domain.
Estimate remediation hours, third-party lab demand, and calendar impact.
Use the output to gate submission timing and staffing decisions.
Cross-check with your line-by-line RTA preparation plan before filing.

Tool 1: Evidence Readiness and Gap Risk Scorer

Rate each domain from 1 (major evidence gap) to 5 (submission-ready evidence package).

Bench Performance Evidence

Biocompatibility Evidence

Sterilization / Reprocessing

Software / Cybersecurity

Labeling and IFU Consistency

Predicate Comparison Strength

Scoring tip: 3 means partial evidence exists but traceability, rationale, or final reports are still incomplete.

Run the calculator to view readiness score, risk band, and recommended action.

Tool 2: Remediation Timeline and Capacity Estimator

Estimate how long gap closure may take based on lab dependency, internal bandwidth, and QA/RA review cycles.

Missing Test Reports

New Protocols Needed

External Lab Lead Time (weeks)

Internal QA/RA Hours per Week

Planned Review Rounds

Program Complexity

Run the estimator to view closure hours, likely calendar duration, and schedule pressure.

Tool 3: Evidence Workstream Sequencing Optimizer

Model whether critical-path acceleration is worth the cost by comparing baseline sequencing versus targeted fast-track execution for your highest-impact evidence workstreams.

High-Impact Workstreams

Baseline Duration per Workstream (weeks)

Current Parallelization (%)

Blocking Dependency Share (%)

Acceleration on Priority Items (%)

Program Burn per Week (USD)

Use this after Tool 2 when you need to decide whether paying for faster lab slots, extra writers, or dedicated QA review is justified.

Run the optimizer to compare baseline and accelerated critical-path timing.

Tool 4: File-Now vs Remediate-First Exposure Estimator

Compare expected schedule and budget exposure across two operating choices: filing with known evidence gaps or delaying to remediate first.

Base Review Duration (days)

Setback Probability if Filing Now (%)

Average Delay if Setback Occurs (days)

Planned Remediation Delay Before Filing (days)

Expected Setback Risk Reduction After Remediation (%)

Weekly Program Burn Rate (USD)

Planning use only: this model supports tradeoff decisions and does not predict FDA outcomes.

Run the estimator to compare expected timeline and burn exposure for both strategies.

Tool 5: eSTAR Section Priority Queue Builder

Turn your current evidence profile into a practical execution queue so teams close the highest-impact sections first.

Hours to recover one readiness point

Criticality multiplier for safety-critical sections

Target readiness score per section (1-5)

This queue uses Tool 1 scores as direct inputs. Run Tool 1 first or manually adjust those fields before running this builder.

Run the builder to generate an ordered closure queue with estimated effort.

Execution Checklist: Before You Lock the Filing Date

Checkpoint	Why It Matters	Owner
Test report traceability map completed	Reduces mismatch between summary claims and appendices.	RA + Technical Lead
Labeling claims align with verified evidence	Avoids review questions about unsupported indications or performance statements.	RA + Marketing/Clinical
Software and cybersecurity narrative reconciled	Prevents fragmented responses across software sections.	Software Lead + RA
Residual-risk rationale documented	Supports coherent benefit-risk discussion when reviewers test assumptions.	Risk Manager
Final RTA pre-check completed line by line	Reduces avoidable front-end screening holds.	Submission Owner

Related 510(k) Utility Pages

Primary References

Planning-use note: this page helps teams structure evidence planning and resource allocation. It does not provide legal advice or replace qualified regulatory review.